entity

Allosteric modulators

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Allosteric modulators: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1Connections
1Hypotheses
1Analyses
1Outgoing
0Incoming
9Experiments
1Debates

No AI portrait yet

Outgoing (1)

TargetRelationTypeStr
tau-HSP90 interaction destabilizationactivatesmechanism0.70

Incoming (0)

SourceRelationTypeStr
No incoming edges

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Fractalkine Axis Amplification via CX3CR1 Positive Allosteri 0.563 neurodegeneration Synaptic pruning by microglia in early A

Mentioning Analyses (1)

Scientific analyses that reference this entity

What are the minimal structural requirements for HSP70/HSP90 inhibitors to achie

drug discovery | 2026-04-09 | 7 hypotheses Top: 0.455

Experiments (9)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
Microglial TREM2 Agonist In Vivo Efficacy validation Alzheimer's Disease 0.450 0.50 mouse proposed $360,000
TREM2 Agonist Therapy for Parkinson's Disease — Experimental Design validation Parkinson's Disease 0.450 0.50 mouse proposed $280,000
TREM2 Function in Alzheimer's Disease — From Risk Variant to Therapeut validation Alzheimer's Disease 0.450 0.50 human proposed $2,960,000
s:** - GPR32 knockout in microglia should worsen neuroinflammation if falsification Neuroinflammation 0.400 0.50 cell_line proposed $80,000
Proposed experiment from debate on Synaptic pruning by microglia in ea falsification Neuroinflammation 0.400 0.50 mouse proposed $240,000
DLB Treatment Response Biomarkers — Predicting Cholinesterase Inhibito clinical Neurodegeneration 0.400 0.50 human proposed $6,550,000
FTD Microglia Role: Protective vs Destructive Mechanism Study validation Neuroinflammation 0.400 0.50 human proposed $2,960,000
Microglial Aging and Immune Memory in Neurodegeneration — Training the validation Alzheimer's Disease 0.400 0.50 human proposed $2,960,000
Microglial Contributions to Huntington's Disease Pathogenesis validation Neuroinflammation 0.400 0.50 human proposed $2,960,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Fractalkine Enhances Hematoma Resolution and Improves Neurological Function via [PMID:37465997] Chen X, He X, Xu F, Xu N, Sharifi NH, Zh Stroke 2023 1
Microglia-Mediated Neuroinflammation: A Potential Target for the Treatment of Ca [PMID:35642214] Wang M, Pan W, Xu Y, Zhang J, Wan J, Jia J Inflamm Res 2022 1
CX3CL1/CX3CR1 signaling targets for the treatment of neurodegenerative diseases. [PMID:34492237] Subbarayan MS, Joly-Amado A, Bickford PC Pharmacol Ther 2022 1
Microglia in neurodegeneration. [PMID:30258234] Hickman S, Izzy S, Sen P, Morsett L, El Nat Neurosci 2018 1
How neuroinflammation contributes to neurodegeneration. [PMID:27540165] Ransohoff RM Science 2016 1
CX3CL1/CX3CR1 axis dysregulation contributes to epileptogenic mechanisms in foca [PMID:41863015] Lei Lei; Shengyu Yang; Yinchao Li; Jiaha Acta neuropathologica communic 2026 0
Constitutive expression of CX3CR1-BAC-Cre introduces minimal off-target effects [PMID:41924777] Mroue-Ruiz FH, Desai B, Garvin MM, Shehu Biochemical and biophysical re 2026 0
Systems-level molecular and immunological evidence identifies Th17/Treg modulati [PMID:41788408] ["Li X", "Li X", "Chen S", "Wang L", "Xi Frontiers in aging neuroscienc 2026 0
Multimodal tumor thermal therapy enhances antitumor immunity by expanding tumor- [PMID:41799205] ["Wang S", "Wang Y", "Zhang Y", "Zhang Z Theranostics 2026 0
[Corrigendum] Influence of aspirin on the CX3CL1/CX3CR1 signaling pathway in acu [PMID:41930567] Zhang Z, Yang W, Ying R, Shi Y, Jiang H Int J Mol Med 2026 0
CX3CR1-T280M polymorphism and end-stage renal disease development in chronic kid [PMID:41932952] Matteo Gatti; Ivano Baragetti; Andrea Ba Scientific reports 2026 0
SYK-dependent lipid handling in monocyte-derived macrophages governs functional [PMID:41831796] ["Zhao Y", "Hu H", "Wang J", "Hu Y", "Ya Brain research bulletin 2026 0
Microglial Lag3 Drives α-Synuclein-induced Neurotoxic Activated (A1) Astrocytes [PMID:41542562] ["Yang X", "Kumbhar R", "Seo B", "Ha S", bioRxiv : the preprint server 2026 0
Conserved ductular reaction mechanisms in biliary atresia and PSC derived from s [PMID:41903685] Schofield A, Kamath BM, MacParland SA, T Cellular and molecular gastroe 2026 0
Identification of suicide brain transcriptomic signatures using meta-analysis of [PMID:41916959] Sokolov AV, Lafta MS, Jokinen J, Schiöth Translational psychiatry 2026 0
Helper T cells and chemokines in elderly asthma - Mechanisms of airway inflammat [PMID:41805218] ["Wu Y"] Biomolecules & biomedicine 2026 0
Identification of metabolism and inflammation-related biomarkers and potential d [PMID:41781900] ["Chen Y", "Zhang M", "Qiao L", "Lu F", BMC psychiatry 2026 0
Chemokine Networks in Blood-Brain Barrier Regulation: Bidirectional Mechanisms, [PMID:41897331] ["Wu Q", "Miao Z", "Lei W", "Wu X", "Zha Biomolecules 2026 0
Two-Sample Bidirectional Mendelian Randomization Analysis of the Causal Relation [PMID:41878553] ["Niu W", "Li J", "Jia H", "Wang L", "Xu Clinical, cosmetic and investi 2026 0
Distinct NK Cell Signatures Define Prognosis in HPV-Positive Versus HPV-Negative [PMID:41827778] ["Li R", "Tong F", "Liu H", "Liu Z", "Li Cancers 2026 0

Debates (1)

Multi-agent debates referencing this entity

What are the minimal structural requirements for HSP70/HSP90 inhibitors to achie

closed · Rounds: 4 · Score: 0.86 · 2026-04-10

Related Research

Hypotheses and analyses mentioning Allosteric modulators in their description or question text

No additional research found